Skip to main content
Log in

Fetal Hydantoin Syndrome with rheumatic valvular heart disease

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Research has shown that anticonvulsants are teratogens and pose a risk for fetal malformations. Though Fetal Hydantoin Syndrome (FHS) was first reported by Langhman and others, wide phenotypic variability of this syndrome has lead many clinicians to question its very existence. We report a twelve year old girl with FHS with rheumatic valvular heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tamier SK, Misra S, Jaiswal S. The offspring of epileptic mother.Indian J Pediatr 1996; 63: 523–531.

    Google Scholar 

  2. Van Dyke DC, Hodge SE, Heide F, Hill LR. Family studies in fetal phenytoin exposure.J Pediatr 1988; 113 (2): 301–306.

    Article  PubMed  Google Scholar 

  3. Collins NMD, Walling KM, Resnick E, Scott WJ. The effect of administration time on malformations induced by three anticonvulsant agents in C 57 BL/6J mice with emphasis on forelimb ectrodactyly.Teratology 1991; 44 (6): 617–627.

    Article  PubMed  CAS  Google Scholar 

  4. Gaily E, Kantola-Sorsa E, Granstom ML. Specific cognitive dysfunction in children with epileptic mothers.Dev Med Child Neurol 1990; 32: 403–414.

    Article  PubMed  CAS  Google Scholar 

  5. Gaily E, Kantola-Sorsa E, Gradstorm ML. Intelligence of children of epileptic mothers.J Pediatr 1988; 113 (4): 677–684.

    Article  PubMed  CAS  Google Scholar 

  6. Nanda A, Kaur S, Bhakoo ON, Kapoor MM, Kanwar AJ. Fetal hydantoin syndrome: a case report.Pediatric Dermatol 1989; 6 (20): 130–133.

    CAS  Google Scholar 

  7. Buechlor BA, Rao V. Finell RH. Biochemical and molecular teratology of fetal hyda ntoin syndrome.Neurol Clin 1994; 12 (4): 741–748.

    Google Scholar 

  8. Finell RH, Buechler BA, Kerr BM, Ager PL, Levy RH. Clinical and experimental studies linking oxidative metabolism to phenytoin induced teratogenesis.Neurology 1992; 42: 25–31.

    Google Scholar 

  9. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of fetus and newborn.Lancet 1972; 11: 839–841.

    Article  Google Scholar 

  10. D’souza SW, Robertson IG, Donnai D, Mawer G. Fetal phenytoin exposure hypoplastic nails and jitteriness.Arch Dis Child 1990; 65: 320–324.

    Article  Google Scholar 

  11. Buechler BA, Delimont D, Van Waes M, Finell RH. Prenatal prediction of risk of the fetal hydantoin syndrome.N Engl J Med 1990; 322 (22): 1567–1572.

    Article  Google Scholar 

  12. Finell RH, Abbott LC, Taylor SM. The fetal hydantoin syndrome: answers from a mouse model.Reprod Toxicol 1989; 3 (2): 127–133.

    Article  Google Scholar 

  13. Strikler SM, Miller MA, Andermann E, Dansky LV, Seni MH, Sppielberg SP. Genetic predisposition to phenytoin induced birth defects.Lancet 1985: 745–749.

  14. Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counselling, management and care of the pregnant women with epilepsy.Neurology 1992; 42: 149–160.

    PubMed  CAS  Google Scholar 

  15. Satpathy R, Bhuyan BK, Das DB, Pant KC, Sarangi J, Pani S. Fetal hydantoin syndrome.J Indian Med Assoc 1990; 88 (6): 168–169.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Godbole, K.G., Gambhir, P.S., Deshpande, A.S. et al. Fetal Hydantoin Syndrome with rheumatic valvular heart disease. Indian J Pediatr 66, 290–293 (1999). https://doi.org/10.1007/BF02761222

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02761222

Key words

Navigation